XCF Global, Inc. (SAFX) Form 10-Q Quarterly Reports
XCF Global, Inc. (SAFX) is a publicly traded company on the Nasdaq, categorized under SIC 2860 (Industrial Organic Chemicals). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SAFX
CIK: 2019793
Exchange: Nasdaq
SIC 2860: Industrial Organic Chemicals
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 9/30/2024 12:00:00 AM
Lead Engagement PartnerTimothy Zechman
Audit LocationDallas, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-16 | — | SCHEDULE 13D/A Filing | 0002106572-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-16 | PRIMARY DOCUMENT | 0002106572-26-000003 | View SEC Doc Filr Page |
| S-4MEF | 2026-10-15 | — | REGISTRATION STATEMENT | 0001213900-26-109703 | View SEC Doc Filr Page |
| PRE 14A | 2026-10-13 | 2026-10-13 | PRE 14A | 0001493152-26-046825 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-05 | CURRENT REPORT | 0001213900-26-107213 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-30 | — | SCHEDULE 13G/A Filing | 0001477932-26-005932 | View SEC Doc Filr Page |
| 425 | 2026-09-24 | — | FORM 425 | 0001213900-26-103061 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | 4 | 0001493152-26-043962 | View SEC Doc Filr Page |
| 424B3 | 2026-09-23 | — | 424B3 | 0001493152-26-043892 | View SEC Doc Filr Page |
| EFFECT | 2026-09-22 | — | EFFECT Filing | 9999999995-26-003035 | View SEC Doc Filr Page |
| EFFECT | 2026-09-21 | — | EFFECT Filing | 9999999995-26-003022 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-15 | CURRENT REPORT | 0001213900-26-100228 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-15 | — | SCHEDULE 13D Filing | 0002106590-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-14 | PRIMARY DOCUMENT | 0002106590-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-14 | 8-K | 0001493152-26-042687 | View SEC Doc Filr Page |
| S-3 | 2026-09-15 | — | S-3 | 0001493152-26-042652 | View SEC Doc Filr Page |
| 425 | 2026-09-15 | — | FORM 425 | 0001213900-26-099861 | View SEC Doc Filr Page |
| 424B3 | 2026-09-14 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-099726 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-14 | — | CURRENT REPORT | 0001213900-26-099725 | View SEC Doc Filr Page |
| 425 | 2026-09-14 | — | CURRENT REPORT | 0001213900-26-099723 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | CURRENT REPORT | 0001213900-26-099716 | View SEC Doc Filr Page |
| RW | 2026-09-14 | — | RW | 0001493152-26-042525 | View SEC Doc Filr Page |
| RW | 2026-09-10 | — | RW | 0001493152-26-042240 | View SEC Doc Filr Page |
| 425 | 2026-09-10 | — | FORM 425 | 0001213900-26-098554 | View SEC Doc Filr Page |
| S-3 | 2026-09-10 | — | S-3 | 0001493152-26-042026 | View SEC Doc Filr Page |